Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-08-22
DOI
10.3389/fimmu.2018.01920
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new lead to NLRP3 inhibition
- (2017) Mohamed Lamkanfi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
- (2017) Hua Jiang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Autophagy and inflammasomes
- (2017) James Harris et al. MOLECULAR IMMUNOLOGY
- The NLRP3 inflammasome in acute myocardial infarction
- (2017) Stefano Toldo et al. Nature Reviews Cardiology
- CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation
- (2017) Tiantian Tang et al. Nature Communications
- Carvedilol suppresses cartilage matrix destruction
- (2016) Zhigang Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Carvedilol protects the kidneys of tumor-bearing mice without impairing the biodistribution or the genotoxicity of cisplatin
- (2016) Maria A. Carvalho Rodrigues et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Design, Synthesis, and Evaluation of Acrylamide Derivatives as Direct NLRP3 Inflammasome Inhibitors
- (2016) Mattia Cocco et al. ChemMedChem
- SIRT1 inhibits inflammatory response partly through regulation of NLRP3 inflammasome in vascular endothelial cells
- (2016) Yanxiang Li et al. MOLECULAR IMMUNOLOGY
- When gout goes to the heart: does gout equal a cardiovascular disease risk factor?
- (2015) Jasvinder A Singh ANNALS OF THE RHEUMATIC DISEASES
- Molecular mechanisms regulating NLRP3 inflammasome activation
- (2015) Eun-Kyeong Jo et al. Cellular & Molecular Immunology
- Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy
- (2015) Ya-Ping Chang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Sulforaphane inhibits multiple inflammasomes through an Nrf2-independent mechanism
- (2015) Allison J. Greaney et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Beta-Blockers: Current State of Knowledge and Perspectives
- (2015) Magdalena Ogrodowczyk et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Inflammasomes: mechanism of action, role in disease and therapeutics
- (2015) Haitao Guo et al. NATURE MEDICINE
- Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
- (2014) Alvin Lu et al. CELL
- Anti-inflammatory therapies for cardiovascular disease
- (2014) P. M. Ridker et al. EUROPEAN HEART JOURNAL
- The Lysosome Rupture-activated TAK1-JNK Pathway Regulates NLRP3 Inflammasome Activation
- (2014) Masahiro Okada et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of Nlrp3 Inflammasomes Enhances Macrophage Lipid-Deposition and Migration: Implication of a Novel Role of Inflammasome in Atherogenesis
- (2014) Xiang Li et al. PLoS One
- Resveratrol Inhibits Ionising Irradiation-Induced Inflammation in MSCs by Activating SIRT1 and Limiting NLRP-3 Inflammasome Activation
- (2013) Yue Fu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Carvedilol Decrease IL-1β and TNF-α, Inhibits MMP-2, MMP-9, COX-2, and RANKL Expression, and Up-Regulates OPG in a Rat Model of Periodontitis
- (2013) Raimundo Fernandes de Araújo Júnior et al. PLoS One
- Lipopolysaccharide/adenosine triphosphate-mediated signal transduction in the regulation of NLRP3 protein expression and caspase-1-mediated interleukin-1β secretion
- (2012) Pei-Chun Liao et al. INFLAMMATION RESEARCH
- Sensing and reacting to microbes through the inflammasomes
- (2012) Luigi Franchi et al. NATURE IMMUNOLOGY
- Carvedilol inhibits Kir2.3 channels by interference with PIP2-channel interaction
- (2011) Tania Ferrer et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome
- (2011) F. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- Adenovirus Type 5 Rupture of Lysosomes Leads to Cathepsin B-Dependent Mitochondrial Stress and Production of Reactive Oxygen Species
- (2011) K. A. McGuire et al. JOURNAL OF VIROLOGY
- A role for mitochondria in NLRP3 inflammasome activation
- (2010) Rongbin Zhou et al. NATURE
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome
- (2010) Kiichi Nakahira et al. NATURE IMMUNOLOGY
- Chemical Modification of Proteins at Cysteine: Opportunities in Chemistry and Biology
- (2009) Justin M. Chalker et al. Chemistry-An Asian Journal
- Cutting Edge: NF- B Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
- (2009) F. G. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- The inhibition in tumor necrosis factor-α-induced attenuation in endothelial thrombomodulin expression by carvedilol is mediated by nuclear factor-κB and reactive oxygen species
- (2009) Pen-Yuan Lin et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More